Publications
- An orally active chemokine receptor CCR2 antagonists prevents glomerulosclerosis and renal failure in type 2diabetes. Commentary on:KI 80,2011,68-782011 | First Faculty of Medicine
- A randomized controlled trial of early versus late initiation of dialysis. IDEAl study.Commentary on:NEJM 363,2010,609-6192010 | First Faculty of Medicine
- Kidney stones and the risk for chronic kidney disease. Commentary on: JASN 4,2009,804-4112009 | First Faculty of Medicine
- Prevalence and risk of hypertension in renal disease - Data from the Czech Registry of Renal Biopsies2008 | First Faculty of Medicine, Third Faculty of Medicine
- Clinical features, outcomes, and response to corticosteroid treatment of acute tubulointerstitial nephritis: a single centre retrospective cohort study in Czech Republic2023 | First Faculty of Medicine, Third Faculty of Medicine
- Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis2023 | First Faculty of Medicine
- Terapeutické možnosti blokády komplementu v léčbě atypického hemolyticko-uremického syndromu2023 | First Faculty of Medicine
- Biologická léčba u nemocných s AL amyloidózou2023 | First Faculty of Medicine
- Budesonid potvrdil efekt v léčbě IgA nefropatie ve studii NefIgArd: konec éry systémových kortikosteroidů?2023 | First Faculty of Medicine
- Biologická léčba u systémových amyloidóz2023 | First Faculty of Medicine
Loading network view...